Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection

Archives of Virology

Volumn 142, Issue 3, 1997, Pages 535-544

  Zignego, A L ^a,c   Fontana, R ^a   Puliti, S ^a   Barbagli, S ^a   Monti, M ^a   Careccia, G ^a   Giannelli, F ^a   Giannini, C ^a   Buzzelli, G ^a   Brunetto, M R ^b   Bonino, F ^b   Gentilini, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c Dipartimento di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; ANTIVIRUS AGENT; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; VIROLOGY;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; RNA, VIRAL;

DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 8244253672     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050099     Document Type: Article

References (30)

1. Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW (1990) Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 46: 423-441
2. Koretz RL, Stone O, Mousa M, Gitnick GL (1985) The NANB post-transfusion hepatitis. A decade later. Gastroenterology 88: 1251-1254
3. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H (1993) A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18: 47-53
4. Zignego AL, Foschi M, Laffi G, Monti M, Careccia G, Romanelli RG, De Majo E, Mazzanti R, Buzzelli G, La Villa G, Gentilini P (1994) "Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. Hepatology 19: 577-582
5. Thiers V, Nakajima E, Krensdorf D, Macke D, Schellekens H, Driss F, Goudeau A (1988) Detection and cloning by the polymerase chain reaction of hepatitis B virus (HBV) DNA sequences in blood samples negative for HBV serologic markers. Lancet 2: 1273-1276
6. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, Prieto J (1992) Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 16: 637-641
7. Hoofnagle JH, Mullen KD, Jones DB, Di Bisceglie A, Peters M, Waggoner JG (1987) Treatment of chronic non-A, non-B hepatitis with recombinant human alpha-interferon. A preliminary report. N Engl J Med 315: 1575-1578
8. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner JG, Goodman Z (1989) Recombinant Interferon alpha therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial. N Engl J Med 321: 1506-1510
9. Alberti A, Chemello L, Bonetti P (1992) Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. J Hepatol 17: S123-126
10. Garson JA, Brillanti S, Whitby K, Foli M, Deaville R, Masci C, Miglioli M, Barbara L (1995) Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C. J Med Virol 45: 348-353
11. Suzuki T, Tanaka E, Matsumoto A, Urushihara A, Sodeyama T (1995) Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon α2a therapy. J Med Virol 46: 162-168
12. Ounanian A, Gueddah N, Rolachon A, Thelu MA, Zarski JP, Seigneurin JM (1995) Hepatitis C virus RNA in plasma and blood mononuclear cells in patients with chronic hepatitis C treated with alpha-interferon. J Med Virol 45: 141-145
13. Matsumoto A, Tanaka E, Suzuky T, Ogata H, Kiyosawa K (1994) Viral and host factors that contribute to efficacy of interferon-α2a therapy in patients with chronic hepatitis C. Dig Dis Sci 39: 1273-1280
14. Perillo RP (1989) Interferon therapy for chronic type B hepatitis: the promise comes of age. Gastroenterology 96: 532-536
15. Fattovich G, Brollo L, Boscaro S, Pontisso P, Giustina G, Criscuolo D, Maladorno D, Alberti A, Realdi G, Ruol A (1989) Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B. J Hepatol 9: 331-337
16. Farci P, Mandas A, Coiana A, Lai ME, Desmet V, Van Eyken P, Gibo Y, Caruso L, Scaccabarozzi S, Criscuolo D, Ryff JC, Balestrieri A (1994) Treatment of chronic hepatitis D with interferon alpha-2a. N Engl J Med 330: 88-94
17. Scotto J, Hadchouel M, Hery C, Yvart J, Tiollais P, Brechot C (1983) Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results of other viral markers. Hepatology 3: 279-284
18. Ferri C, Marzo E, Longobardo G, Lombardini F, La Civita L, Bombardieri S, Zignego AL (1993) Alpha-interferon in mixed cryoglobulinemia patients: a randomized crossover controlled trial. Blood 81: 1132-1136
19. Colloredo Mels G, Bellati G, Leandro G, Brunetto MR, Vicari O, Piantino P, Borzio M, Angeli G, Ideo G, Bonino F (1993) Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations. Arch Virol [Suppl] 8: 203-211
20. Okada SI, Akahane Y, Suzuki H, Okamoto H, Mishiro S (1992) The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16: 619-624
21. Lau J Y-N, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC (1993) Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341: 1501-1504
22. Serfaty L, Giral P, Loria A, Andreani T, Legendre C, Poupon R (1994) Factors predictive of the response to interferon in patients with chronic hepatitis C. J Hepatol 21: 12-17
23. Magrin S, Craxi A, Fabiano C, Simonetti RG, Fiorentino G, Marino, Diquattro O, Di Marco V, Loiacono O, Volpes R, Almasio P, Urdea MS, Neuwald P, Sancez-Pescador R, Detmer J, Wilber JC, Pagliaro L (1994) Hepatitis C viremia in chronic liver disease: relationship to interferon-α or corticosteroid treatment. Hepatology 19: 273-279
24. Pozzato G, Kaneko S, Moretti M, Crocè LS, Franzin F, Unoura M, Bercih L, Tiribelli C, Crovatto M, Santini G, Kobayashi K (1994) Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 43: 291-296
25. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Brechot C (1992) Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 15: 382-386
26. Zignego AL, De Carli M, Monti M, Careccia G, La Villa G, Giannini C, D'Elios MM, Del Prete G, Gentilini P (1995) Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. J Med Virol 47: 58-64
27. Zignego AL, Barbagli S, Mazzanti R, Foschi M, Rossi S, Laffi G, Buzzelli G, Gentilini P (1991) Therapy of chronic active hepatitis C with α-interferon: effectiveness and prognostic factors. In: Gentilini P, Dianzani MU (eds) Experimental and clinical hepatology. Excerpta Medica, Amsterdam, pp 253-259
28. Marinos G, Smith HM, Naoumov NV, Williams R (1994) Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection. Hepatology 19: 303-311
29. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A (1993) Clinical and virological profiles in patients with multiple hepatitis virus infection. Gastroenterology 105: 1529-1533
30. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A (1994) Clinical and virological profiles in patients with multiple hepatitis virus infection. Gastroenterology 107: 322-323 (Comment)